Screener
Solid Biosciences Inc. SLDB Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | $44,265 | $32,415 | $90,405 | $63,329 |
| General and administrative | 13,119 | 9,278 | 24,287 | 18,416 |
| Total operating expenses | 57,384 | 41,693 | 114,692 | 81,745 |
| Loss from operations | (57,384) | (41,693) | (114,692) | (81,745) |
| Other income, net: | ||||
| Interest income | 3,221 | 2,966 | 5,285 | 5,266 |
| Interest expense | — | (60) | — | (128) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Solid Biosciences Inc.'s other operating expenses?
- Solid Biosciences Inc. (SLDB) reported other operating expenses of $57.38M in Q2 2026.
- How has Solid Biosciences Inc.'s other operating expenses changed year-over-year?
- Solid Biosciences Inc.'s other operating expenses increased by 37.6% year-over-year, from $41.69M to $57.38M.
- What is the long-term trend for Solid Biosciences Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s other operating expenses has grown at a 20.2% compound annual growth rate (CAGR), from $85.87M to $179.21M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Solid Biosciences Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude